These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29805067)

  • 1. The synergistic effects of IL-6/IL-17A promote osteogenic differentiation by improving OPG/RANKL ratio and adhesion of MC3T3-E1 cells on hydroxyapatite.
    Sritharan S; Kannan TP; Norazmi MN; Nurul AA
    J Craniomaxillofac Surg; 2018 Aug; 46(8):1361-1367. PubMed ID: 29805067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17A promotes osteogenic differentiation by increasing OPG/RANKL ratio in stem cells from human exfoliated deciduous teeth (SHED).
    Sebastian AA; Kannan TP; Norazmi MN; Nurul AA
    J Tissue Eng Regen Med; 2018 Aug; 12(8):1856-1866. PubMed ID: 29774992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
    Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
    Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.
    Lee DW; Kwon JY; Kim HK; Lee HJ; Kim ES; Kim HJ; Kim HJ; Lee HB
    Int J Med Sci; 2018; 15(7):723-729. PubMed ID: 29910677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells.
    Li F; Yang Y; Zhu P; Chen W; Qi D; Shi X; Zhang C; Yang Z; Li P
    Fitoterapia; 2012 Dec; 83(8):1443-50. PubMed ID: 22951288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
    Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
    Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
    Lavocat F; Osta B; Miossec P
    Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients].
    Xu Y; Ya XP; Zhang WJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):521-4. PubMed ID: 22803436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icariin Stimulates hFOB 1.19 Osteoblast Proliferation and Differentiation via OPG/RANKL Mediated by the Estrogen Receptor.
    Sun LJ; Li C; Wen XH; Guo L; Guo ZF; Liao LQ; Guo Y
    Curr Pharm Biotechnol; 2021; 22(1):168-175. PubMed ID: 31971108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous administration of fluoride and selenite regulates proliferation and apoptosis in murine osteoblast-like MC3T3-E1 cells by altering osteoprotegerin.
    Ren G; Wang K; Chang R; Su Y; Wang J; Su J; Han B
    Biol Trace Elem Res; 2011 Dec; 144(1-3):1437-48. PubMed ID: 21739163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establish mouse osteoblast -osteoclast cell co-culture system in a Transwell chamber].
    Mo GY; Zhang SC; Li YX; Guo HZ; Guo DQ; Li DX; Tang YC; Mo L; Luo PJ; Ma YH
    Zhongguo Gu Shang; 2018 Mar; 31(3):241-247. PubMed ID: 29600675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
    Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
    BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line.
    Ren H; Ren H; Li X; Yu D; Mu S; Chen Z; Fu Q
    Mol Med Rep; 2015 Nov; 12(5):6711-7. PubMed ID: 26398911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro].
    Liu CG; Luo QX; Ling TY; Mo YY; Cheng ZL; Huang SG; Mo H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1658-64. PubMed ID: 24517065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of technetium-99 conjugated with methylene diphosphonate (
    Shen S; Wang W; Yang C; Xu B; Zeng L; Qian Y
    J Oral Pathol Med; 2019 Feb; 48(2):129-135. PubMed ID: 30421571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Kruger MC
    J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphocreatine Promotes Osteoblastic Activities in H
    Jing Z; Wang C; Wen S; Jin Y; Meng Q; Liu Q; Wu J; Sun H; Liu M
    Curr Pharm Biotechnol; 2021; 22(5):609-621. PubMed ID: 33198615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.